Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease - Wikidata - awgldk - TriplyDB

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

http://www.wikidata.org/entity/Q30495250

about

Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface The pericyte: a forgotten cell type with important implications for Alzheimer's disease?The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium Contribution of blood platelets to vascular pathology in Alzheimer's disease Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease Fibrinogen α-chain-derived peptide is upregulated in hippocampus of rats exposed to acute morphine injection and spontaneous alternation testing.The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration.Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.Sphingolipids affect fibrinogen-induced caveolar transcytosis and cerebrovascular permeability.Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain In vivo imaging of the neurovascular unit in CNS disease.A turning point for Alzheimer's disease?Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease Networks in Coronary Heart Disease Genetics As a Step towards Systems Epidemiology APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.Microangiopathy in the cerebellum of patients with mitochondrial DNA disease Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Inferring novel gene-disease associations using Medical Subject Heading Over-representation Profiles.Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease.The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.Blood protein predictors of brain amyloid for enrichment in clinical trials?Repeated systemic inflammation was associated with cognitive deficits in older Britons The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen Vasodilation by in vivo activation of astrocyte endfeet via two-photon calcium uncaging as a strategy to prevent brain ischemia.Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

P2860

Q26781646-93149DAE-7F53-4B25-9242-8A2FFDA19196 Q26852369-0F59B048-C239-4105-8AB5-DBF4902F0E1E Q26859190-7E711FB1-B382-4FB1-B0B2-A02714DD12F7 Q26861509-999602E0-D081-450B-8F9D-77FAB9EC84AF Q26995130-3D63359B-CC25-4C8C-B358-9F323D73547B Q28488690-4E94B6F0-4666-4B2E-BFF7-E614F9211938 Q28537832-8C12703E-638F-420A-9783-ECABC0BF3657 Q28740917-3E074F5B-D3E0-448F-AA99-C811F31481B5 Q29248210-E8221AA2-6DF2-4167-B7DB-D6A3DC9AB8F8 Q29347027-E8406026-51FC-4730-A22F-DCF106DBD1D9 Q30440606-68D273C8-CE76-4021-811F-26EB3FA0A8B7 Q30512264-E28CB2EA-D0CD-4478-AD35-4C9497BA509C Q30579707-79134AB7-37CD-4C1E-80F5-EA84A90CAB54 Q31050722-C4920A0B-92D3-4A52-BA36-431A12342932 Q33745920-8FD86156-AD60-4F66-981A-F8E3CF6CF540 Q33913018-6AA5A8BB-5FAE-4E5B-8B88-6707EAA3C292 Q33969588-BEB227FD-E6AA-4410-86CB-ED184024D88F Q33997270-2E2092B1-6B93-40D9-9F53-8988B26A0021 Q34138247-100A5330-DB81-4396-A06F-6846200709F4 Q34197623-6C3E3C7B-4F8D-4FD3-AB95-AAF507DB0451 Q34411401-65EC9184-42CE-4890-982E-A269AF8996CB Q35141182-FEB835F2-E4DB-4A47-AB59-8DE9F1FA1E20 Q35624353-85BC5D20-E179-4D56-A321-6E3DD7A67A51 Q35825824-9B6CB377-1466-4CA0-8522-6E1EA55B7EF0 Q35876959-7819792C-B6BC-44F8-A2F1-6E9479715611 Q35986703-4DCBF153-9BAE-45CD-AF80-9854C97B7DBF Q36351793-920BC7FC-2294-49CF-8D27-F8F0070B69CE Q36546334-85B1CC2B-8AA0-414E-9284-4C39E85632F9 Q36632948-E8AD1051-2DF1-4533-A941-F4D66F021698 Q36635045-129FE3C1-27F6-4D0F-BD40-827426CE2186 Q36681693-836DCC27-066C-40B0-83EF-458EBDD87C44 Q36909451-74FB4215-A19F-420A-BE56-6722880618D9 Q36926754-86EF894A-0F89-4B77-99D9-6017C0652E3E Q36934141-684CCC36-BE7C-4CB0-BB5F-5095799E00E9 Q37073413-0E7FA10A-4AC1-49B2-BEED-2D4B44BFA6D7 Q37104293-C0992E18-182D-4C35-987E-87A6C21B56BA Q37112216-316E8F01-6A81-49DD-A71F-75D35634A4A4 Q37398788-B6AC3D47-F522-4D71-9251-61F8C1DB2272 Q37698598-B46A3D11-AB53-4197-A93F-7DDC5A41EC3D Q37812906-6C3622A6-B550-4A46-B8E5-5B823D27F5E2

P2860

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

http://www.wikidata.org/entity/Q30495250

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@ast

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@en

type

label

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@ast

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@en

prefLabel

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@ast

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@en

P1433

Q30495250-3212CD83-3628-47D3-9A34-9EAE725A88F9

P1476

Q30495250-C14DECD2-6811-4ED4-B495-95EDAFC35697

P2093

Q30495250-418B25C0-720F-46E3-8961-7FD364401657

Q30495250-52BF0287-3774-4917-8190-D70B645A3FDA

Q30495250-670E6B00-55FC-4A29-8817-50BEDF657120

Q30495250-98911AB2-062E-4A0E-B09C-C7E080CF6A96

Q30495250-A2456989-6B7B-4850-BB8A-CE35E86E922B

P2860

Q30495250-0472C14C-FC07-47DA-A854-EFF0C3B5648E

Q30495250-05074449-D3B4-45DA-9056-3F5E7DDAE628

Q30495250-05C42975-ADEA-481C-B259-54678895F33D

Q30495250-0B844684-C9F1-45AC-AA50-4AAD816D9286

Q30495250-0CB8002B-E804-4BF9-944A-4E1B06D19203

Q30495250-1E54081C-C13E-4385-976E-5D99EC4049F1

Q30495250-20AEC318-1A01-4936-819F-16D56153A54D

Q30495250-21AC8036-1048-4CDE-9A3B-B103B18A9728

Q30495250-25A9F566-AE4E-4581-822F-B51E9A84DAC9

Q30495250-260CCA83-8DE8-4F63-BE92-3EB471C38845

P304

Q30495250-F28C5D35-152D-49B6-96A0-91FFF807BE42

P31

Q30495250-361FED37-8D87-442C-91AE-BE59D78B575C

P356

Q30495250-58A56455-7704-4FD0-98F2-B4E69E8CD509

P407

Q30495250-AB69D05A-9966-423C-9BA6-EA549F426063

P433

Q30495250-2CD99F1B-EF4E-4779-BBDE-5DF9FE78676C

P478

Q30495250-04476EDB-3F4F-4664-A897-F65E524A03F5

P50

Q30495250-037E7C48-CDE5-45D8-96A5-254402BD3DE5

Q30495250-AB067D55-38D8-4B18-B465-3A0FDDCE858C

Q30495250-CBB63432-CCAA-4F54-BE52-3A5A34BED63C

Q30495250-F106A4E4-6F73-4DE5-B5C6-3D047BDE0454

P577

Q30495250-274B6595-6D49-4199-8F5C-67CB86AB7192

P5875

Q30495250-DA50907F-F4C1-47F8-A770-F7FC9EA25BFE

P698

Q30495250-41D9A76C-9B39-49E8-96B1-99E7C5B92488

P921

Q30495250-84F05233-40C5-4863-86FA-DAF6CFABF8D7

Q30495250-8764F394-FC5C-46B4-ABFB-4A29336082F8

P932

Q30495250-16CBF40F-2981-42DC-9FF0-76CDF0426B53

P356

J.NEURON.2010.05.014

P1433

P1476

Fibrinogen and beta-amyloid as ...... factor to Alzheimer's disease

@en

P2093

Daria Zamolodchikov

http://www.w3.org/2001/XMLSchema#string

Justin Paul

http://www.w3.org/2001/XMLSchema#string

Marta Cortes-Canteli

http://www.w3.org/2001/XMLSchema#string

Robert Bronstein

http://www.w3.org/2001/XMLSchema#string

Shivaprasad Bhuvanendran

http://www.w3.org/2001/XMLSchema#string

P2860

Clearance of amyloid-beta by circulating lipoprotein receptors

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Neurovascular regulation in the normal brain and in Alzheimer's disease

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Fibrillar amyloid beta-protein forms a membrane-like hydrophobic domain.

Targeted insult to subsurface cortical blood vessels using ultrashort laser pulses: three models of stroke.

Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease

P304

695-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEURON.2010.05.014

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Sidney Strickland

Katherine M Fenz

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44672341

http://www.w3.org/2001/XMLSchema#string

P698

20547128

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2895773

http://www.w3.org/2001/XMLSchema#string